A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
Clinical trial NCT06292923 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06292923
- Sponsor
- Tiziana Life Sciences LTD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-15
- Primary completion
- 2026-09-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.